Skip to content

Effective dose of aspirin for prevention of a type of hypertension in pregnancy

EFFICACY OF ASPIRIN 75 mg VS 150 mg FOR PREVENTION OF PREECLAMPSIA IN MULTIMARKER SCREEN POSITIVE HIGH RISK WOMEN.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/034646
Enrollment
96
Registered
2021-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O100- Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

Interventions

Intervention1: aspirin 75 mg versus aspirin 150 mg: above doses will be given in antenatal patients and maternal outcome will be analysed Control Intervention1: Aspirin different dose: Aspirin 75mg ve

Sponsors

Balram pandit
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: �Previous history of preeclampsia �nulliparity �short( �h/o ART �family h/o chronic hypertension. �Obesity (BMI >29.9) �comorbidities like SLE, chronic hypertension, APS, kidney disease, DM

Exclusion criteria

Exclusion criteria: 1.allergic to aspirin and aspirin is contra indicated for medical reasons 2.refusal for consent 3.significant fetal malformations or presence of aneuploidy 4.low platelet count 5. patient on anticoagulation 6. patient already on aspirin

Design outcomes

Primary

MeasureTime frame
1 Incidence of preterm preeclampsia in both groups. 2 Complications of preeclampsia like HELLP, Eclampsia, acute kidney injury and postpartum eclampsia Timepoint: 1 year

Secondary

MeasureTime frame
.Incidence of antepartum and postpartum hemorrhage Gestation at delivery, mode of delivery. Need for blood transfusion and hospitalization for maternal or fetal indication. Development of IUGR, IUFD, fetal distress, neonatal death. Hemorrhagic disease of new born, respiratory distress in the newborn APGAR score, duration of NICU stay of the baby Timepoint: 1 YEAR

Countries

India

Contacts

Public ContactDr SC saha

PGIMER chandigarh

drscsaha@gmail.com9417591558

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026